Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Idexx Laboratories
IDXX
$40.4B
| $78.3M | 0.14% |
694,304
+156,900
| +29% | +$16.5M |
2013 Q2
13 quarters
|
|
152
Berkshire Hathaway Class A
BRK.A
$1.1T
| $78.1M | 0.14% |
361
+88
| +32% | +$19.3M |
2015 Q1
6 quarters
|
|
153
Charles River Laboratories
CRL
$14B
| $78M | 0.14% |
935,909
+155,800
| +20% | +$13.1M |
2013 Q2
13 quarters
|
|
154
Gen Digital
GEN
$13.6B
| $77.9M | 0.14% |
3,102,038
-400,141
| -11% | -$9.1M |
2015 Q3
4 quarters
|
|
155
Toronto Dominion Bank
TD
$186B
| $77.8M | 0.14% |
1,752,300
+239,200
| +16% | +$10.5M |
2013 Q2
13 quarters
|
|
|
PXD
156
DELISTED
Pioneer Natural Resource Co.
PXD
| $76.7M | 0.14% |
413,388
-14,005
| -3% | -$2.38M |
2016 Q2
1 quarter
|
|
157
Pan American Silver
PAAS
$18.7B
| $76.2M | 0.13% |
4,323,817
-1,521,700
| -26% | -$28.5M |
2013 Q2
13 quarters
|
|
158
Ultrapar
UGP
$8.34B
| $75.9M | 0.13% |
6,935,200
-1,425,400
| -17% | -$15.9M |
2013 Q2
13 quarters
|
|
|
MZTI
159
The Marzetti Company
MZTI
$2.78B
| $75.9M | 0.13% |
574,500
-35,000
| -6% | -$4.57M |
2013 Q2
13 quarters
|
|
160
Booking.com
BKNG
$119B
| $75.6M | 0.13% |
+1,284,975
| New | +$71.6M |
2016 Q3
0 quarters
|
|
161
AutoZone
AZO
$47.2B
| $75.6M | 0.13% |
98,400
+68,700
| +231% | +$53.5M |
2015 Q3
4 quarters
|
|
|
NTRI
162
DELISTED
NutriSystem, Inc.
NTRI
| $75.2M | 0.13% |
2,532,500
+32,600
| +1% | +$919K |
2013 Q2
13 quarters
|
|
163
British American Tobacco
BTI
$119B
| $74.7M | 0.13% |
1,171,000
+98,400
| +9% | +$6.24M |
2014 Q2
9 quarters
|
|
164
Biogen
BIIB
$32.3B
| $74.6M | 0.13% |
238,261
+197,861
| +490% | +$58.6M |
2016 Q1
2 quarters
|
|
|
DD
165
DELISTED
Du Pont De Nemours E I
DD
| $74.1M | 0.13% |
1,106,800
+701,400
| +173% | +$47.6M |
2016 Q1
2 quarters
|
|
166
TSMC
TSM
$2.37T
| $74.1M | 0.13% |
2,422,451
-354,000
| -13% | -$10.1M |
2013 Q2
13 quarters
|
|
167
Eli Lilly
LLY
$1.03T
| $74M | 0.13% |
922,200
-1,269,005
| -58% | -$102M |
2015 Q3
4 quarters
|
|
168
Annaly Capital Management
NLY
$13.7B
| $73.8M | 0.13% |
1,757,527
-914,348
| -34% | -$39.6M |
2014 Q3
8 quarters
|
|
169
Boeing
BA
$148B
| $73.2M | 0.13% |
555,300
+528,000
| +1,934% | +$69.6M |
2016 Q2
1 quarter
|
|
170
Equinor
EQNR
$102B
| $72.6M | 0.13% |
4,321,600
-158,698
| -4% | -$2.58M |
2015 Q1
6 quarters
|
|
|
AZPN
171
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $71.8M | 0.13% |
1,534,500
-41,300
| -3% | -$1.93M |
2013 Q2
13 quarters
|
|
|
TFCFA
172
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $71.7M | 0.13% |
2,960,400
+778,400
| +36% | +$19.9M |
2016 Q2
1 quarter
|
|
173
Post Holdings
POST
$3.35B
| $70.2M | 0.12% |
1,390,786
+237,146
| +21% | +$13M |
2015 Q3
4 quarters
|
|
174
Telephone and Data Systems
TDS
$3.93B
| $70.1M | 0.12% |
2,578,792
+171,800
| +7% | +$5.01M |
2013 Q2
13 quarters
|
|
|
TARO
175
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $69.6M | 0.12% |
629,900
+9,000
| +1% | +$1.19M |
2013 Q2
13 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.